Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2003
03/27/2003CA2423945A1 Restrainers of airway mucus secretion
03/27/2003CA2423885A1 Thiazole and oxazole derivatives
03/26/2003EP1295872A1 Drug composition antagonistic to both pgd 2?/txa 2? receptors
03/26/2003EP1294905A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294856A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors
03/26/2003EP1294718A2 6,5-fused bicyclic heterocycles
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294697A1 1,2,3,5-tetrahydrobenzo[c]azepin-4-one derivatives having muscarinic antagonist activity
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
03/26/2003EP1294686A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
03/26/2003EP1294411A1 A novel treatment for cough
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294395A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1294376A2 Medicament for combating respiratory depression
03/26/2003EP1294368A1 Management of snoring by oral administration of dimethyl sulfone
03/26/2003EP1294366A1 Pharmaceutical compounds for treating copd
03/26/2003EP1294362A1 Novel process for preparing crystalline particles
03/26/2003EP1294357A1 Bioavailable dosage form of isotretinoin
03/26/2003EP1294353A1 Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
03/26/2003EP1200431B1 Quinuclidine derivatives and their use as muscarinic m3 receptors ligands
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1087735B1 Adhesively applied external nasal strips and dilators containing medications and fragrances
03/26/2003EP1027325B1 Lipophilic diesters of chelating agents
03/26/2003EP0998477B1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
03/26/2003EP0801563B1 The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
03/26/2003CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405314A Cryptoporus volvatus fermented product, and its preparation method and application
03/26/2003CN1404859A Compound tablet of Chinese medicine for clearing out kakostomia and treating acute pharyngitis and preparation thereof
03/26/2003CN1404854A Medicine for treating nosal inflammation
03/26/2003CN1404853A Medicine for treating tonsillitis and laryngopharyngitis
03/26/2003CN1103781C Abundant extracellular product and methods for production and use of same
03/26/2003CN1103773C 二氮杂萘衍生物 Naphthyridine derivative
03/26/2003CN1103760C 1,3-dihydro-2H-imidazol-2-one derivatives having PDEIV and cytokinin inhibiting activity
03/26/2003CN1103600C Medicinal composition of treating asthma and pulmonary hypertension
03/26/2003CN1103599C Medicinal composition for treating asthma and its preparation method
03/25/2003US6538035 And treatment of Chronic Obstructive Pulmonary Disease and allergic rhinitis
03/25/2003US6538017 Anticoagulants; cardiovascular disorders; central nervous system disorders
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6538005 As inhibitors of phosphodiesterases; therapy
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537550 Preventing bacterial infection of lungs or bronchi in cystic fibrosis patient
03/25/2003US6537524 Inflammatory or obstructive airways disease
03/25/2003CA2107961C Injectable mesna solutions
03/21/2003WO2002026702A1 Phenoxyphenyl alkane sulfonates
03/21/2003CA2423171A1 Phenoxyphenyl alkane sulfonates
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022799A1 Ccr-3 receptor antagonists v
03/20/2003WO2003022787A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003WO2003022309A1 Remedies for allergic diseases
03/20/2003WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
03/20/2003WO2003022284A1 Methods of treating pulmonary disease
03/20/2003WO2003022279A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022275A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines
03/20/2003WO2003022273A1 Methods of treating cytokine mediated diseases
03/20/2003WO2003022266A1 Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
03/20/2003WO2003022253A1 Dosage forms having prolonged active ingredient release
03/20/2003WO2002100319A3 Method for cleaning hard gelatine capsules
03/20/2003WO2002087424A3 Treatment and diagnosis of macrophage mediated disease
03/20/2003WO2002083113A3 Aerosol compositions containing formoterol and a steroid such as e.g. budesonide or fluticasone for delivery into the lungs via nebulization
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003WO2002066040A8 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002052269A3 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002038726A3 Paramyxovirus vector for gene transfer to the cardiovascular system
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002012245B1 Azabicyclic derivatives and their therapeutic use
03/20/2003WO2001078894A3 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
03/20/2003US20030055286 Il-8 receptor antagonists
03/20/2003US20030055260 Il-8 receptor antagonists
03/20/2003US20030055258 New crystal modification of torasemide
03/20/2003US20030055250 Pteridine compounds for the treatment of psoriasis
03/20/2003US20030055248 Il-8 receptor antagonists
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055102 For therapy of allergic or inflammatory disorders of the eye and nose
03/20/2003US20030055098 Method of treatment
03/20/2003US20030055097 Indazolyl-substituted pyrroline compounds as kinase inhibitors
03/20/2003US20030055095 Administering to the patient a therapeutically effective amount of a compound that is an MEK inhibitor for inhibiting neutrophil migration
1 ... 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 ... 878